Delivery Order SPE2DR25D1004-SPE2DR26FSTW1
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Bicillin L-A 2,400,000 units in 4ml formulations, valued at $2,732.81 with a firm fixed price structure. The order is scheduled for completion by October 24, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order represents a non-competitive, non-set-aside award issued under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 10, 2025, for the supply of Bicillin L-A 1,200,000 units in 2ML vials, with a ceiling value of $4,245.72 and a completion date of June 11, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is being fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters. This...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Bicillin L-A 1,200,000 Units 2ML, with a ceiling value of $5,709.85 and an ultimate completion date of June 2, 2025. This delivery order was competitively awarded with no set-aside designation and represents a procurement under the company's broader pharmaceutical supply agreement with DLA. The place of performance is AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $138,579.84 on June 2, 2025, for the supply of Bicillin L-A 1,200,000 units in 2ML formulation. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The ultimate completion date for this delivery order is June 3,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Bicillin L-A 2,400,000 units (4mL) on September 9, 2025, with a ceiling value of $7,568.94. This firm fixed-price delivery order represents a non-competitive set-aside procurement and is scheduled for ultimate completion by September 10, 2025. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Bicillin L-A 2,400,000 units in 4mL vials, with a contract ceiling value of $5,967.49 and an ultimate completion date of September 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Bicillin L-A 1,200,000 units in 2ml formulations, with a ceiling value of $14,887.08. This competitively awarded, firm fixed-price delivery order is scheduled for completion by April 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's pharmaceutical supply relationship with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 13, 2025, for the supply of Bicillin L-A 1,200,000 units in 2ML formulations, with a contract ceiling value of $2,887.08. This is a firm fixed price delivery order with no set-aside designation, reflecting open and competitive procurement. The order is scheduled for ultimate completion by May 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $227,966.84 to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of Bicillin L-A (penicillin G benzathine) 1,200,000 units in 2 mL formulations. This is a firm fixed-price contract with an ultimate completion date of June 5, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a non-competitive set-aside contract, indicating direct competition through the open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 29, 2025, for the supply of Bicillin L-A 1,200,000 Units 2ML, an antibiotic pharmaceutical product. The contract is valued at $123,697.64 with firm fixed pricing and a completion date of May 30, 2025. This is a non-set-aside, competitively awarded delivery order that will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's...
- SPE2DR25D1004Indefinite Delivery Contract
- SPE2DR25D1004-SPE2DR26FSTW1Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Bicillin L-A 2,400,000 units in 4 milliliter formulations. This is a firm fixed-price delivery order with a ceiling value of $2,732.81 and an ultimate completion date of October 24, 2025. The award was made on a competitive basis with no set-aside designation, and the product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement and military healthcare systems. Bicillin L-A, a penicillin-based antibiotic, is a standard pharmaceutical product within the company's extensive portfolio of brand-name and generic medications supplied through the DLA Medical Supply Chain. The award reflects AmerisourceBergen's established capability to fulfill federal medical supply requirements through open competition, consistent with its track record of delivering specialized pharmaceuticals and medical supplies to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 10/23/25 |